Bank Of America Corp Idera Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.23 - $0.43 $23 - $43	102 Added 10.2%	1,102 $0
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.53 $38 - $53	-100 Reduced 9.09%	1,000 $0
Q2 2022 Aug 12, 2022	BUY	$0.32 - $0.74 $32 - $74	100 Added 10.0%	1,100 $0
Q1 2022 May 16, 2022	SELL	$0.41 - $0.7 $102 - $175	-250 Reduced 20.0%	1,000 $0
Q4 2021 Feb 08, 2022	SELL	$0.53 - $1.03 $42,804 - $83,186	-80,764 Reduced 98.48%	1,250 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.0 - $1.18 $80,838 - $95,388	80,838 Added 6873.98%	82,014 $84,000
Q2 2021 Sep 13, 2021	BUY	$1.01 - $1.58 $1,187 - $1,858	1,176 New	1,176 $1,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.